First-in-human trial demonstrates safety, encouraging functional response in chronic phases of recovery
IV thrombolysis should not be delayed because of planned thrombectomy
Case series demonstrates successful retreatment of this rare emergency
Retrospective looks at a “direct to angio” MSU strategy and mechanical thrombectomy beyond 24 hours
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic’s approach to improve care transitions and patient safety
Multidisciplinary efforts to refine cerebral hemodynamic goals in a high-risk population
Medication-focused intervention key to management success in a challenging population
Comparative MRI study suggests unique pathophysiology in COVID-19 context
Advice on why and how based on Cleveland Clinic’s recent enterprise-wide transition
First-in-man trial demonstrates safety, promising functional response rates
Advertisement
Advertisement